Thor Medical ASA (OSL:TRMED)

Norway flag Norway · Delayed Price · Currency is NOK
2.470
-0.035 (-1.40%)
Jul 16, 2025, 4:25 PM CET
135.24%
Market Cap874.21M
Revenue (ttm)n/a
Net Income (ttm)-42.21M
Shares Out348.99M
EPS (ttm)-0.18
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume766,583
Average Volume3,745,366
Open2.500
Previous Close2.505
Day's Range2.465 - 2.510
52-Week Range0.956 - 4.990
Beta-0.21
RSI46.48
Earnings DateAug 29, 2025

About Thor Medical ASA

Thor Medical ASA produces and supplies alpha-particle emitters for cancer therapy in Norway. It develops Ra224, an isotope of radium; Pb-212, a radioactive isotope of lead; and Th-228, a radioactive isotope of thorium. The company was incorporated in 2009 and is headquartered in Oslo, Norway. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2009
Employees 9
Stock Exchange Oslo Børs
Ticker Symbol TRMED
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.